Abstract Purpose JCOG1109 was a three-arm randomized phase III trial to confirm the survival advantage of docetaxel plus cisplatin 5-fluorouracil (DCF) and (CF) combined with radiotherapy (CF-RT) over CF as preoperative treatment for locally advanced esophageal squamous cell carcinoma. The purpose this study evaluate impact thoracic duct (TD) resection, its association pathological response in ...